Creative Medical Technology Holdings, Inc. Common Stock
$0.88
Market Cap
$5.42M
Shares Outstanding
6.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 30, 2009
Round Lot
100
Locale
US
Day Open
$0.86
Day High
$0.90
Day Low
$0.83
Volume
180.3K
VWAP
$0.86
Prev Close
$0.82
Transactions
--
Acc. Volume
--
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Creative Medical Technology Holdings, Inc. Common Stock (CELZ) closed the 2026-09-17 session at $0.88, up 6.75% versus the previous close (+0.06). The stock opened at $0.86 and traded between $0.83 and $0.90 during that session. Session trading volume was 180K shares. The volume-weighted average price (VWAP) is $0.86.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Creative Medical Technology Holdings, Inc. Common Stock has a market capitalization of $5.4 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. CELZ is listed on the XNAS exchange. The company employs approximately 4 people. Creative Medical Technology Holdings, Inc. Common Stock is headquartered in PHOENIX, AZ. The recorded listing date is 2009-04-30.
On this page you can find market CELZ stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.